Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Real-World Outcomes Associated With Afatinib (Gilotrif) Use in Patients With Solid Tumors Harboring NRG1 Gene Fusions

NCT04750824 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT04750824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Real-World Outcomes Associated With Afatinib (Gilotrif) Use in Patients With Solid Tumors Harboring NRG1 Gene Fusions
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
December 20, 2021
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous, non-small cell lung cancer